Genetic Technologies Limi...

NASDAQ: GENE · Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM

Genetic Income Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
13.29M 12.64M 12.64M 13.43M 16.31M 13.83M 13.83M 11.4M 11.4M 6.76M 4.54M 2.51M 788.98K 685.45K 26.3K 16.91K
Cost of Revenue
13.7M 17.4M 17.4M 13.27M 14.22M 9.77M 9.77M 4.64M 4.64M 3.29M 2.35M 1.33M 920.02K 653.76K 647.48K 645.98K
Gross Profit
-408.71K -4.75M -4.75M 155.54K 2.09M 4.06M 4.06M 6.77M 6.77M 3.47M 2.19M 1.18M -131.04K 31.69K -621.18K -629.07K
Operating Income
-13.22M -15.14M -15.14M -14.29M -16.11M -16.5M -16.5M -13.06M -13.06M -12.93M -12.97M -12.44M -14.56M -13.47M -11.6M -10.55M
Interest Income
259.93K 310.03K 310.03K 256.42K 261.54K 131.92K 131.92K 57.57K 57.57K 74.8K 96.42K 93.04K 110.09K 63.85K 37.11K 40.16K
Pretax Income
-18.32M -18.33M -18.33M -16.38M -18.02M -16.81M -16.81M -13.14M -13.14M -12.73M -12.89M -11.82M -13.68M -12.67M -10.86M -10.82M
Net Income
-18.31M -18.17M -18.17M -15M -16.63M -14.22M -14.22M -10.7M -10.7M -11.05M -11.23M -10.82M -12.33M -11.38M -9.57M -9.4M
Selling & General & Admin
13.26M 11.47M 11.47M 16.42M 19.28M 19.21M 19.21M 17.4M 17.4M 10.5M 8.94M 8.47M 8.74M 8.99M 7.7M 6.74M
Research & Development
1.48M 1.67M 1.67M -144.31K 22.96K 1.43M 1.43M 1.06M 1.06M 4.53M 4.42M 3.35M 4.51M 3.59M 3.54M 3.44M
Other Expenses
1.93M 2.75M 2.75M 1.84M 1.84M 823.92K 823.92K n/a n/a n/a n/a n/a n/a 258.08K 258.08K 258.08K
Operating Expenses
12.81M 10.39M 10.39M 14.44M 18.03M 20.38M 20.38M 19.65M 19.65M 16.22M 15.13M 13.59M 14.41M 13.47M 10.98M 9.92M
Interest Expense
65.27K 42.37K 42.37K 29.52K 29.52K 31.86K 31.86K 15.99K 15.99K 22.61K 22.61K 14.05K 21.63K 22.25K 22.25K 14.82K
Selling & Marketing Expenses
4.12M 4.2M 4.2M 4.09M 4.66M 4.26M 4.26M 3.06M 3.06M 2.08M 1.6M 1.29M 1.2M 1.32M 1.24M 984.23K
Cost & Expenses
26.51M 27.78M 27.78M 27.72M 25.08M 22.98M 22.98M 10.89M 10.89M 6.12M 6.28M 3.72M 10.34M 9.14M 11.63M 10.57M
Income Tax Expense
-10.32K -158.33K -158.33K -1.38M -1.36M -2.56M -2.56M -2.41M -2.41M -1.65M -1.67M -997.91K -1.35M -1.29M -1.29M -1.42M
Shares Outstanding (Basic)
4.97M 134.07K 134.07K 107.26K 107.26K 107.26K 107.26K 102.5K 102.5K 10.25M 102.2K 10.22M 99.06K 9.89M 90.83K 56.91K
Shares Outstanding (Diluted)
4.97M 134.07K 134.07K 107.26K 107.26K 107.26K 107.26K 102.5K 102.5K 10.25M 102.2K 10.22M 99.06K 9.89M 90.83K 56.91K
EPS (Basic)
-11.7 -15.6 -15.6 -14.1 -14.1 -12 -12 -6.9 -6.9 -7.5 -7.5 -7.5 -13.5 -17.1 -17.1 -23.1
EPS (Diluted)
-11.7 -15.6 -15.6 -14.1 -14.1 -12 -12 -6.9 -6.9 -7.5 -7.5 -7.5 -13.5 -17.1 -17.1 -23.1
EBITDA
-17.54M -17.13M -17.13M -15.11M -16.9M -15.82M -15.82M -12.57M -12.57M -12.18M -12.17M -11.17M -13.04M -12.27M -10.48M -10.47M
EBIT
-15.62M -15.58M -15.58M -14.89M -16.71M -14.94M -16.76M -9.54M -11.37M -10.96M -9.13M -8.06M -11.86M -10.84M -10.84M -10.81M
Depreciation & Amortization
583.5K 957.25K 957.25K 1.04M 1.07M 933.97K 933.97K 768.87K 768.87K 741.89K 747.84K 674.38K 632.02K 438.11K 407.05K 381.57K